Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Patients Who May Benefit Most Tirzepatide may be appropriate for patients who: Struggle to lose weight despite consistent effort Have prediabetes or Type 2 diabetes Experience PCOS-related weight gain Have elevated fasting insulin levels Carry excess abdominal or visceral fat Have a family history of diabetes Who May Not Be a Candidate Tirzepatide may not be appropriate for patients with: A history of medullary thyroid cancer Certain endocrine disorders Pregnancy or breastfeeding Severe gastrointestinal intolerance without supervision All eligibility decisions at Geneva are physician evaluated
Access the form: This questionnaire gathers your essential health history, current medications, and weight loss goals to confirm your eligibility for GLP-1 treatment
PlexusDx clinicians track these early markers to confirm you're on the right medication pathway for your genetic profile
Smoothies with protein powder, fruit, nut butter, and milk pack significant nutrition into a drinkable format
Commonly Reported Side Effects of BPC-157 Not every patient experiences side effects
